title: Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).
abstract: BACKGROUND
  Randomized clinical trials (RCTs) stopped early for benefit often receive great attention and affect clinical practice, but pose interpretational challenges for clinicians, researchers, and policy makers. Because the decision to stop the trial may arise from catching the treatment effect at a random high, truncated RCTs (tRCTs) may overestimate the true treatment effect. The Study Of Trial Policy Of Interim Truncation (STOPIT-1), which systematically reviewed the epidemiology and reporting quality of tRCTs, found that such trials are becoming more common, but that reporting of stopping rules and decisions were often deficient. Most importantly, treatment effects were often implausibly large and inversely related to the number of the events accrued. The aim of STOPIT-2 is to determine the magnitude and determinants of possible bias introduced by stopping RCTs early for benefit.
  
  
  METHODS
  We will use sensitive strategies to search for systematic reviews addressing the same clinical question as each of the tRCTs identified in STOPIT-1 and in a subsequent literature search. We will check all RCTs included in each systematic review to determine their similarity to the index tRCT in terms of participants, interventions, and outcome definition, and conduct new meta-analyses addressing the outcome that led to early termination of the tRCT. For each pair of tRCT and systematic review of corresponding non-tRCTs we will estimate the ratio of relative risks, and hence estimate the degree of bias. We will use hierarchical multivariable regression to determine the factors associated with the magnitude of this ratio. Factors explored will include the presence and quality of a stopping rule, the methodological quality of the trials, and the number of total events that had occurred at the time of truncation.Finally, we will evaluate whether Bayesian methods using conservative informative priors to "regress to the mean" overoptimistic tRCTs can correct observed biases.
  
  
  CONCLUSIONS
  A better understanding of the extent to which tRCTs exaggerate treatment effects and of the factors associated with the magnitude of this bias can optimize trial design and data monitoring charters, and may aid in the interpretation of the results from trials stopped early for benefit.
authors: Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada. brielm@uhbs.ch
authors: Matthias
authors: M
authors: Briel
authors: Melanie
authors: M
authors: Lane
authors: Victor M
authors: VM
authors: Montori
authors: Dirk
authors: D
authors: Bassler
authors: Paul
authors: P
authors: Glasziou
authors: German
authors: G
authors: Malaga
authors: Elie A
authors: EA
authors: Akl
authors: Ignacio
authors: I
authors: Ferreira-Gonzalez
authors: Pablo
authors: P
authors: Alonso-Coello
authors: Gerard
authors: G
authors: Urrutia
authors: Regina
authors: R
authors: Kunz
authors: Carolina Ruiz
authors: CR
authors: Culebro
authors: Suzana Alves
authors: SA
authors: da Silva
authors: David N
authors: DN
authors: Flynn
authors: Mohamed B
authors: MB
authors: Elamin
authors: Brigitte
authors: B
authors: Strahm
authors: M Hassan
authors: MH
authors: Murad
authors: Benjamin
authors: B
authors: Djulbegovic
authors: Neill K J
authors: NK
authors: Adhikari
authors: Edward J
authors: EJ
authors: Mills
authors: Femida
authors: F
authors: Gwadry-Sridhar
authors: Haresh
authors: H
authors: Kirpalani
authors: Heloisa P
authors: HP
authors: Soares
authors: Nisrin O
authors: NO
authors: Abu Elnour
authors: John J
authors: JJ
authors: You
authors: Paul J
authors: PJ
authors: Karanicolas
authors: Heiner C
authors: HC
authors: Bucher
authors: Julianna F
authors: JF
authors: Lampropulos
authors: Alain J
authors: AJ
authors: Nordmann
authors: Karen E A
authors: KE
authors: Burns
authors: Sohail M
authors: SM
authors: Mulla
authors: Heike
authors: H
authors: Raatz
authors: Amit
authors: A
authors: Sood
authors: Jagdeep
authors: J
authors: Kaur
authors: Clare R
authors: CR
authors: Bankhead
authors: Rebecca J
authors: RJ
authors: Mullan
authors: Kara A
authors: KA
authors: Nerenberg
authors: Per Olav
authors: PO
authors: Vandvik
authors: Fernando
authors: F
authors: Coto-Yglesias
authors: Holger
authors: H
authors: Schünemann
authors: Fabio
authors: F
authors: Tuche
authors: Pedro Paulo M
authors: PP
authors: Chrispim
authors: Deborah J
authors: DJ
authors: Cook
authors: Kristina
authors: K
authors: Lutz
authors: Christine M
authors: CM
authors: Ribic
authors: Noah
authors: N
authors: Vale
authors: Patricia J
authors: PJ
authors: Erwin
authors: Rafael
authors: R
authors: Perera
authors: Qi
authors: Q
authors: Zhou
authors: Diane
authors: D
authors: Heels-Ansdell
authors: Tim
authors: T
authors: Ramsay
authors: Stephen D
authors: SD
authors: Walter
authors: Gordon H
authors: GH
authors: Guyatt
mesh_terms: D001499:Bayes Theorem; D015982:Bias; D026661:Clinical Trials Data Monitoring Committees; D003657:Decision Making; D019317:Evidence-Based Medicine; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000379:methods* / Q000706:statistics & numerical data*; D016896:Treatment Outcome